Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 63629-8524

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 63629-8524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298524)

Label (Lbl636298524)
Label for Olmesartan Medoxomil Tablets, USP 40 mg by Bryant Ranch Prepack. The label shows the NDC 63629-8524-1, product strength 40 mg in a black-bordered box, and a quantity of 90 tablets. It includes storage instructions and states the product is Rx only.*
FDA Label Image

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)
Chemical structure of olmesartan medoxomil, the active ingredient in the oral film-coated tablet formulation labeled by Bryant Ranch Prepack.*
FDA Label Image

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)
A line graph showing the dose response of olmesartan medoxomil on placebo-adjusted reduction in blood pressure. The X-axis represents olmesartan medoxomil dose in mg, ranging from 0 to 80 mg. The Y-axis shows the reduction in systolic and diastolic blood pressure in mmHg. Two lines depict the effects on systolic BP and diastolic BP, both increasing with dose but at different rates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.